prof. dr. R.E.G. Schutgens

Full Professor

  • Hematology/Van Creveldclinic

prof. dr. R.E.G. Schutgens


Roger Schutgens is a Consultant Haematologist at the University Medical Centre Utrecht. His main responsibilities include care, research and education in the area of benign hematology and clotting diseases. Prof. Schutgens is the Head of at the Van Creveldkliniek, a national expertise center for rare and/or inherited benign hematologic disorders, thrombosis and haemostasis. He completed his medical degree from Catholic University Leuven, Leuven, Belgium and he completed his PhD from Utrecht University, Utrecht, The Netherlands. Prof. Schutgens areas of focus include patients predisposed to bleeding, congenital abnormalities of platelets and hypercoagulable conditions.

Side Activities

  • Advisory Board Member Horizonscan geneesmiddelen ZonMW since 1-10-2018

Research Output (180)

A Pathophysiological Perspective on the SARS-CoV-2 Coagulopathy

Kusadasi Nuray, Sikma Maaike, Huisman Albert, Westerink Jan, Maas Coen, Schutgens Roger aug 2020, In: HemaSphere. 4 6 p.

Abnormal coagulation parameters are a common non-neuromuscular feature in patients with spinal muscular atrophy

Wijngaarde Camiel A., Huisman Albert, Wadman Renske I., Cuppen Inge, Stam Marloes, Heitink-Pollé Katja M.J., Groen Ewout J.N., Schutgens Roger E.G., Van Der Pol W. Ludo feb 2020, In: Journal of Neurology, Neurosurgery and Psychiatry. 91 , p. 212-214 3 p.

The Perspectives of Adolescents and Young Adults on Adherence to Prophylaxis in Hemophilia:A Qualitative Study

Hoefnagels J W, Kars M C, Fischer K, Schutgens Reg, Schrijvers L H 23 jan 2020, In: Patient Preference and Adherence. 14 , p. 163-171 9 p.

Congenital platelet disorders and health status-related quality of life

Blaauwgeers Maaike W, Kruip Marieke J H A, Beckers Erik A M, Coppens Michiel, Eikenboom Jeroen, van Galen Karin P M, Tamminga Rienk Y J, Urbanus Rolf T, Schutgens Roger E G, jan 2020, In: Research and practice in thrombosis and haemostasis. 4 , p. 100-105 6 p.

Maternal and neonatal bleeding complications in relation to peripartum management in women with Von Willebrand disease:A systematic review

Punt M. C., Waning M. L., Mauser-Bunschoten E. P., Kruip M. J.H.A., Eikenboom J., Nieuwenhuizen L., Makelburg A. B.U., Driessens M. H.E., Duvekot J. J., Peters M., Middeldorp J. M., Bloemenkamp K. W.M., Schutgens R. E.G., Lely A. T., Van Galen K. P.M. 24 okt 2019, In: Blood Reviews. 39 9 p.

Catheter Ablation for Atrial Fibrillation in Patients with Hemophilia or von Willebrand Disease

van der Valk Paul R, Mauser-Bunschoten Eveline P, van der Heijden Jeroen F, Schutgens Roger E G okt 2019, In: TH open : companion journal to thrombosis and haemostasis. 3 , p. e335-e339

Reliability and Feasibility of the Self-Administered ISTH-Bleeding Assessment Tool

Punt Marieke C, Blaauwgeers Maaike W, Timmer Merel A, Welsing Paco M J, Schutgens Roger E G, van Galen Karin P M okt 2019, In: TH open : companion journal to thrombosis and haemostasis. 3 , p. e350-e355

One piece of the puzzle: Population pharmacokinetics of FVIII during perioperative Haemate P (R)/Humate P (R) treatment in von Willebrand disease patients:Population pharmacokinetics of FVIII during perioperative Haemate P<sup>®</sup>/Humate P<sup>®</sup> treatment in von Willebrand disease patients

de Jager Nico C.B., Bukkems Laura H., Heijdra Jessica M., Hazendonk Carolien H.C.A.M., Fijnvandraat Karin, Meijer Karina, Eikenboom Jeroen, Laros - van Gorkom Britta A.P., Leebeek Frank W.G., Cnossen Marjon H., Mathôt Ron A.A., Collins P. W., Kruip M. J.H.A., Polinder S., Lock J., van Moort I., Goedhart M. C.H.J., Coppens M., Peters M., Preijers T., Brons P., van der Meer F. J.M., Schutgens R. E.G., Fischer K., Driessens M. H.E., Zwaan C. M., van Vliet I., Liesner R., Chowdary P., Keeling D., 26 sep 2019, In: Journal of Thrombosis and Haemostasis. 18 , p. 295-305 11 p.

The Paediatric Haemophilia Activities List (pedHAL) in routine assessment:changes over time, child-parent agreement and informative domains

Kuijlaars Isolde A.R., van der Net Janjaap, Schutgens Roger E.G., Fischer Kathelijn 16 aug 2019, In: Haemophilia. 25 , p. 953-959 7 p.

Antifibrinolytic therapy for preventing oral bleeding in patients with haemophilia or Von Willebrand disease undergoing minor oral surgery or dental extractions

van Galen Karin Pm, Engelen Eveline T, Mauser-Bunschoten Evelien P, van Es Robert JJ, Schutgens Roger EG 19 apr 2019, In: Cochrane Database of Systematic Reviews . 2019

All Research Output (180)